Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024...
Vous n'êtes pas connecté
Pharvaris provides business update and expands development program for deucrictibant Pharvaris today announced: The planned initiation of CHAPTER-3, the pivotal Phase 3 study of deucrictibant extended-release tablets for the prophylactic treatment of HAE Its intention to pursue clinical development of deucrictibant in a newly named indication, acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH) Presented [...]
Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024...
Pharvaris presents data at the Bradykinin Symposium 2024 Pharvaris announced a summary of data being presented at the ongoing 7th Bradykinin...
The SBI Foundation has expanded the eligibility for its Youth for India Fellowship program to include Overseas Citizens of India (OCIs), Citizens of...
The Board of Directors of the African Development Bank Group (“ADB”) approved $102.79 million for the Multinational (Guinea, Senegal and Togo)...
Intellia Therapeutics to present data from the Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE) at the 2024 ACAAI Annual...
The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...
The approval expands the label of TVTX's Filspari in IgAN indication. However, the label also comes with a boxed warning for liver problems and...
Trial investigating Cabometyx® (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for one of the...
The African Development Bank Group (AfDB) Board of Directors approved $102.79 million for the Multinational (Guinea, Senegal and Togo) Promotion of...
MEOH acquires OCI's methanol business for $2.05 billion, boosting global production and entering the ammonia market.